Cholesterol lowering in the elderly population. Coordinating Committee of the National Cholesterol Education Program

Arch Intern Med. 1999 Aug;159(15):1670-8. doi: 10.1001/archinte.159.15.1670.

Abstract

The incidence of coronary heart disease (CHD) peaks in the elderly population. In secondary and primary prevention trials, cholesterol-lowering therapy reduces risk for CHD in both older and younger participants. This benefit, therefore, can be extended to the elderly.

Publication types

  • Review

MeSH terms

  • Aged
  • Anticholesteremic Agents / therapeutic use
  • Cholesterol / blood*
  • Clinical Trials as Topic
  • Coronary Angiography
  • Coronary Disease / blood
  • Coronary Disease / diagnostic imaging
  • Coronary Disease / etiology
  • Coronary Disease / prevention & control*
  • Humans
  • Hypercholesterolemia / blood*
  • Hypercholesterolemia / complications
  • Hypercholesterolemia / drug therapy
  • Hypercholesterolemia / therapy*
  • Patient Selection
  • Risk Factors
  • Sex Factors
  • United States

Substances

  • Anticholesteremic Agents
  • Cholesterol